SE9603669D0 - New combination - Google Patents

New combination

Info

Publication number
SE9603669D0
SE9603669D0 SE9603669A SE9603669A SE9603669D0 SE 9603669 D0 SE9603669 D0 SE 9603669D0 SE 9603669 A SE9603669 A SE 9603669A SE 9603669 A SE9603669 A SE 9603669A SE 9603669 D0 SE9603669 D0 SE 9603669D0
Authority
SE
Sweden
Prior art keywords
active ingredient
new combination
kit
composition
salt
Prior art date
Application number
SE9603669A
Other languages
English (en)
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603669A priority Critical patent/SE9603669D0/sv
Publication of SE9603669D0 publication Critical patent/SE9603669D0/sv
Priority to PCT/SE1997/001606 priority patent/WO1998015280A1/en
Priority to SK751-98A priority patent/SK75198A3/sk
Priority to CA002239308A priority patent/CA2239308A1/en
Priority to AU45782/97A priority patent/AU715319B2/en
Priority to KR1019980704266A priority patent/KR19990071975A/ko
Priority to EP97944242A priority patent/EP0871450A1/en
Priority to NZ330482A priority patent/NZ330482A/xx
Priority to BR9706822A priority patent/BR9706822A/pt
Priority to HU9901674A priority patent/HUP9901674A3/hu
Priority to CZ981761A priority patent/CZ176198A3/cs
Priority to PL97327037A priority patent/PL327037A1/xx
Priority to JP10517442A priority patent/JP2000502365A/ja
Priority to TW086114371A priority patent/TW470647B/zh
Priority to ZA9708889A priority patent/ZA978889B/xx
Priority to ARP970104615A priority patent/AR013614A1/es
Priority to MYPI97004698A priority patent/MY128337A/en
Priority to NO982414A priority patent/NO982414L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
SE9603669A 1996-10-08 1996-10-08 New combination SE9603669D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination
JP10517442A JP2000502365A (ja) 1996-10-08 1997-09-24 新規な組み合わせ
BR9706822A BR9706822A (pt) 1996-10-08 1997-09-24 Composição kit processo para tratamento de um distúrbio respiratório e utilização da composição do kit de formoterol de um sal ou solvato farmaceuticamente aceitável do mesmo e de budesonida
CZ981761A CZ176198A3 (cs) 1996-10-08 1997-09-24 Nový prostředek
CA002239308A CA2239308A1 (en) 1996-10-08 1997-09-24 New combination
AU45782/97A AU715319B2 (en) 1996-10-08 1997-09-24 New combination
KR1019980704266A KR19990071975A (ko) 1996-10-08 1997-09-24 신규한복합조성물
EP97944242A EP0871450A1 (en) 1996-10-08 1997-09-24 New combination
NZ330482A NZ330482A (en) 1996-10-08 1997-09-24 Compositions comprising formoterol and budesonide for treating respiratory disorders
PCT/SE1997/001606 WO1998015280A1 (en) 1996-10-08 1997-09-24 New combination
HU9901674A HUP9901674A3 (en) 1996-10-08 1997-09-24 New pharmaceutical combination
SK751-98A SK75198A3 (en) 1996-10-08 1997-09-24 Pharmaceutical composition
PL97327037A PL327037A1 (en) 1996-10-08 1997-09-24 Novel combination
TW086114371A TW470647B (en) 1996-10-08 1997-10-02 Composition and pharmaceutical combination kit comprising formoterol and budesonide
ZA9708889A ZA978889B (en) 1996-10-08 1997-10-03 New combination of steroids.
ARP970104615A AR013614A1 (es) 1996-10-08 1997-10-07 Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
MYPI97004698A MY128337A (en) 1996-10-08 1997-10-07 New combination of steroids
NO982414A NO982414L (no) 1996-10-08 1998-05-27 Ny kombinasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination

Publications (1)

Publication Number Publication Date
SE9603669D0 true SE9603669D0 (sv) 1996-10-08

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination

Country Status (18)

Country Link
EP (1) EP0871450A1 (sv)
JP (1) JP2000502365A (sv)
KR (1) KR19990071975A (sv)
AR (1) AR013614A1 (sv)
AU (1) AU715319B2 (sv)
BR (1) BR9706822A (sv)
CA (1) CA2239308A1 (sv)
CZ (1) CZ176198A3 (sv)
HU (1) HUP9901674A3 (sv)
MY (1) MY128337A (sv)
NO (1) NO982414L (sv)
NZ (1) NZ330482A (sv)
PL (1) PL327037A1 (sv)
SE (1) SE9603669D0 (sv)
SK (1) SK75198A3 (sv)
TW (1) TW470647B (sv)
WO (1) WO1998015280A1 (sv)
ZA (1) ZA978889B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
JP2002510310A (ja) * 1997-06-27 2002-04-02 アストラ・アクチエボラーグ 抗喘息薬の新規配合
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SE9900834D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (sv) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combinationspartiklar för astmaterapi
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
AU2007264418B2 (en) 2006-06-30 2012-05-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
PE20081788A1 (es) 2007-02-19 2008-12-18 Cipla Ltd Combinaciones farmaceuticas
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
KR101976107B1 (ko) 2009-05-29 2019-05-09 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
WO2013128283A2 (en) 2012-02-28 2013-09-06 Iceutica Holdings Inc. Bvi Inhalable pharmaceutical compositions
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0004452D0 (sv) * 1991-12-18 2001-01-29 Astra Ab

Also Published As

Publication number Publication date
AU4578297A (en) 1998-05-05
HUP9901674A3 (en) 2001-04-28
BR9706822A (pt) 1999-03-23
HUP9901674A2 (hu) 1999-09-28
SK75198A3 (en) 1998-11-04
WO1998015280A1 (en) 1998-04-16
KR19990071975A (ko) 1999-09-27
NO982414D0 (no) 1998-05-27
AR013614A1 (es) 2001-01-10
CA2239308A1 (en) 1998-04-16
EP0871450A1 (en) 1998-10-21
CZ176198A3 (cs) 1998-09-16
TW470647B (en) 2002-01-01
AU715319B2 (en) 2000-01-20
JP2000502365A (ja) 2000-02-29
PL327037A1 (en) 1998-11-09
ZA978889B (en) 1998-04-08
NZ330482A (en) 1999-11-29
NO982414L (no) 1998-05-27
MY128337A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
SE9603669D0 (sv) New combination
ATE390133T1 (de) Gabapentinanaloga für schlafstörungen
MY132705A (en) Novel compounds with analgesic effect
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
DE69721766D1 (de) Neue arzneiformulierung
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
WO2002036562A3 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
SE9704644D0 (sv) New use
CA2199844A1 (en) Compositions for the treatment of skin disorders
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
ATE226084T1 (de) Wundheilung und behandlung von fibrose
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
DE69521122T2 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
BG102667A (en) Diosgenine-containing composition
HUP0002361A2 (hu) Halogén-benzimidazol-származék alapú, szinergetikus hatású fungicid kompozíció ellőállítása és felhasználása
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
EP0373771A3 (en) New pharmaceutical uses for cystatins
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
ID26132A (id) Pembuatan untuk pengobatan dari gangguan fungsi ereksi
DE59705183D1 (de) Therapeutische mittel, enthaltend ebselen gegen asthma